CheckMyRecalls

Novartis Pharmaceuticals Corporation recalls Diovan (valsartan) 160 mg

Published
19 Aug 2026
Agency
FDA
Country
United States

The hazard

Failed Dissolution Specifications

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Diovan (valsartan) 160 mg, 90 tablets, Rx only, Manufactured by: Patheon Manufacturing Services LLC, Greenville, NC 27834, Distributed by: Novartis Pharmaceutical Corp, East Hanover, NJ 07936, NDC 0078-0359-34

Brand / company
Novartis Pharmaceuticals Corporation
Codes / lots
Lot AV5913C, Expiry: 6/2027
Distribution
US Nationwide
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 19 Aug 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.